Search results for "cancer du pancréas"

Through its research programs, Inserm aims to facilitate and accelerate discoveries and their transformation into tangible progress for patients and society. In this sense, the Institute is developing a research environment that is conducive to interactions between basic, translational, and clinical research. Inserm is also participating in the steering and implementation of France’s national health research […]

The objectives of public health research are to understand the influence of factors that determine population health and propose interventions and health policies based on scientific knowledge and evidence. These actions serve to improve health and well-being and reduce health inequalities. At Inserm, over 110 teams are dedicated to public health research. Public health researchers […]

With her research on how the nervous system influences the regulation of immunity, Sophie Ugolini is charting an unprecedented course in immunology. When she turned her attention to it in 2012 after several years of deciphering immune regulation mechanisms, immunology was a new discipline. This bold choice has earned Ugolini two major funding opportunities which, […]

In the October 2023 issue, discover our special feature Ageing: What if we could reverse it?

By exploring the diversity of the structure and composition of pancreatic cancers, Rémy Nicolle wants to identify avenues that will rapidly bring new treatments to patients. This translational research, which combines genomics, transcriptomics and artificial intelligence, was selected as part of the Atip-Avenir program in 2022. Pancreatic adenocarcinoma accounts for 85% of all pancreatic cancers. It is […]

Established as part of a partnership between Inserm and CNRS, each year the ATIP-Avenir program facilitates the creation of research teams in the fields of life sciences and health for approximately twenty young researchers. To date, this program has provided support to over 400 promising scientists. Created in 1990 and 2000 respectively, and subsequently merged in […]

Inserm brings together 15,000 researchers, engineers, technicians and administrative staff, all with one shared objective: improve health by advancing knowledge about living organisms and diseases, developing innovative treatment modalities and conducting research on public health. Improve human health Since it was founded in 1964, Inserm has played an active role in major medical breakthroughs, including […]

An expert in rare neurodegenerative diseases, Pascale Bomont has obtained European funding enabling her to boost her research. Research that aims to elucidate the role of the cytoskeleton in a healthy or diseased nervous system. This could lead to the development of treatments for a wide range of diseases related to disorders of this internal […]

The Signal and Image Processing Laboratory (LTSI) celebrated its 50th anniversary last November. Intended for military applications when it launched in 1969, this Inserm/Université de Rennes 1 Joint Research Unit now devotes itself entirely to the application of digital sciences to health. « We provide doctors with interpretation and decision-support tools to improve the treatment of […]

From his beginnings in molecular biology to the neuroscience research conducted by his unit, Denis Vivien’s career has been remarkable. Curious and determined, he has never ceased to set up research projects and structures at the cutting edge of innovation and he has been entrusted with numerous academic responsibilities. Today, his fundamental discoveries on the […]